Nisa Investment Advisors LLC lowered its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 2.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 233,610 shares of the company’s stock after selling 6,901 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $21,237,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. XTX Topco Ltd bought a new position in shares of Colgate-Palmolive during the 2nd quarter valued at about $423,000. Mount Yale Investment Advisors LLC purchased a new stake in shares of Colgate-Palmolive in the second quarter worth about $421,000. EverSource Wealth Advisors LLC boosted its stake in Colgate-Palmolive by 79.7% during the second quarter. EverSource Wealth Advisors LLC now owns 3,504 shares of the company’s stock valued at $348,000 after buying an additional 1,554 shares during the last quarter. Evergreen Capital Management LLC grew its holdings in Colgate-Palmolive by 4.2% during the 2nd quarter. Evergreen Capital Management LLC now owns 3,490 shares of the company’s stock valued at $339,000 after buying an additional 141 shares in the last quarter. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its stake in Colgate-Palmolive by 59.9% in the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 149,787 shares of the company’s stock worth $14,535,000 after acquiring an additional 56,103 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.
Insider Activity at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.37% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on CL
Colgate-Palmolive Stock Down 0.8 %
Shares of NYSE CL opened at $87.53 on Thursday. The stock has a 50 day moving average price of $92.07 and a 200 day moving average price of $97.65. The firm has a market capitalization of $71.51 billion, a price-to-earnings ratio of 25.08, a PEG ratio of 3.64 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $80.03 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.
Colgate-Palmolive Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Oracle Announces Game-Changing News for the AI Industry
- What Is WallStreetBets and What Stocks Are They Targeting?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Trading Stocks: RSI and Why it’s Useful
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.